Pricing Experiments: Pharmas Get Creative in Germany

As Germany's insurers try out new drug reimbursement tactics, innovative pharmas have responded with novel, brand-boosting payor deals of their own. The evolution of these payor-pharma deals in Germany should inform reimbursement strategies elsewhere--including in the US where similar trends are starting to emerge.

Melanie Senior

Germany has historically been one of Europe's most attractive pharmaceutical markets. It's the continent’s biggest, with a population of over...

In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

More from Global Vision

More from In Vivo